Track RAMM Pharma's receivables ($330K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (July 2026), RAMM.CN shows a receivables of $330K. That compares with $840K in the prior-year period — down 60.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, RAMM.CN's receivables is now $330K (was $840K) — a 60.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether RAMM Pharma is outperforming or lagging.
Tracking RAMM.CN's receivables over time shows whether RAMM Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $330K That compares with $840K in the prior-year period — down 60.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has RAMM Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $330K) with ownership activity and broader fundamentals.